Treatment of human breast cancer MDA-MB-231 and MCF-7 cells with DOX resulted in significant increases in UBC9 in both whole cellular and nuclear extracts in a dose- and time-dependent manner (Fig. 7a). The gene discussed is UBE2I; the disease is breast carcinoma.